Signals
Why some “resistant” hypertension isn’t resistant at all, and what cardiology might be missing
A new HCPLive expert discussion highlights growing attention to hypercortisolism as a possible contributor to resistant hypertension and difficult-to-control cardiometabolic disease. Emerging data from MOMENTUM and CATALYST suggest cortisol excess may be more common in these high-risk groups than previously assumed. The policy challenge is not simply whether to screen more patients. It is who…
The Most Preventable Cause of Vision Loss May Still Be Smoking
Global cardiovascular policy shifts accelerate, but diverging strategies expose uneven progress
Corxel’s oral GLP-1 trial adds momentum. The real question is who these drugs will reach
Eight Patients Cannot Solve Alzheimer’s. They Can Tell Us What the Next Trial Must Prove.
The ICU Has a New Signal. It Is Not a Verdict.
West Nile Is Back. Blood Safety Cannot Lag.
Deep learning uncovers a new ECG biomarker for sudden cardiac death
Half of CKM patients go untreated and most fail control
The Trial Has Started. Now the System Has to Find the Children.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.